PetVivo Holdings, Inc. Partners with VetStem, Inc. to Offer Innovative Veterinary Solutions

Breaking News: Innovative Orthobiologic Products Now Available for Canine and Equine Use

MINNEAPOLIS, MN, Feb. 14, 2025 (GLOBE NEWSWIRE) —

In an exciting development for the veterinary medical industry, PetVivo Holdings, Inc. has announced a partnership with VetStem, Inc. to bring cutting-edge orthobiologic products to the market. This collaboration will see the commercialization of VetStem’s groundbreaking allogeneic products, PrecisePRP® canine and PrecisePRP® equine.

PrecisePRP® represents a significant advancement in veterinary medicine, offering veterinarians access to a first-in-class off-the-shelf platelet-rich plasma (PRP) product. Designed specifically for use in canines and equines, this innovative solution is set to revolutionize the way we approach orthobiologics in veterinary care.

With PetVivo Holdings, Inc. leading the charge in bringing these products to the market, veterinarians and pet owners alike can look forward to enhanced treatment options and improved outcomes for their beloved animals.

How This Partnership Will Impact You:

As a pet owner, this partnership means access to cutting-edge veterinary treatments that can improve the health and well-being of your furry friends. With PrecisePRP® now available, veterinarians will have a powerful tool at their disposal to provide more effective care for injuries, arthritis, and other orthopedic conditions in both dogs and horses.

How This Partnership Will Impact the World:

The collaboration between PetVivo Holdings, Inc. and VetStem, Inc. has the potential to raise the standard of veterinary care on a global scale. By introducing innovative orthobiologic products like PrecisePRP® to the market, we can improve the quality of life for animals around the world, offering new hope and healing where it is needed most.

Conclusion:

Exciting times lie ahead in the world of veterinary medicine, thanks to the partnership between PetVivo Holdings, Inc. and VetStem, Inc. With the commercialization of PrecisePRP® canine and PrecisePRP® equine, we are witnessing a groundbreaking shift in how we approach orthobiologics in veterinary care. As a pet owner, this means access to cutting-edge treatments that can improve the health and well-being of our beloved animals. On a global scale, this partnership has the potential to revolutionize veterinary care and make a lasting impact on the lives of animals everywhere.